Cannabis News and Research

Latest Cannabis News and Research

Research shows the importance of stopping drug use in early adulthood

Young people who use drugs but quit before adulthood are – on average – not harming their future life chances, according to new research which tracked thousands of people over a 16-year period.

23 Feb 2022

Scientific statement highlights the uncertainty about health effects of marijuana

Despite the perception that marijuana is harmless, there is some scientific evidence challenging that belief, and there are many unanswered questions about its impact on brain health, according to a new American Heart Association scientific statement published today in the Association's journal Stroke.

10 Feb 2022

HORIBA Presenting Short Course on Rapid Analysis of Hemp/Cannabis and other Botanicals with Pittcon

February 9, 2022 – Piscataway, NJ HORIBA Scientific, a global leader in the production of high-performance spectroscopy systems and solutions, is presenting a short course with the Pittcon organization, entitled, “Rapid Analysis of Hemp/Cannabis and other Botanicals using Simultaneous Absorbance-Transmission and Fluorescence Excitation Emission Matrix (A-TEEM) Spectroscopy.”

From HORIBA 9 Feb 2022

Study finds gender-based differences in risk factors associated with anxiety during the pandemic

The COVID-19 pandemic is an anxiety-inducing stressor that affects every aspect of our daily lives. A new Canadian study has found that the pandemic-related risk-factors associated with anxiety differ between men and women.

9 Feb 2022

Cannabis combined with alcohol is more detrimental to driving, finds study

New research published today in the scientific journal Addiction has found that cannabis combined with alcohol is more detrimental to driving performance than either used in isolation. This meta-analysis merged the findings of 57 studies representing about 1,725 participants.

27 Jan 2022

Study explores how cannabis use affects driving performance

The steady rise in the use of cannabis - 18 states have legalized recreational use, 13 have decriminalized its use and 36 have medical cannabis laws - has provoked myriad questions and concerns about public health implications, including how cannabis may affect the abilities, real and perceived, of drivers under the influence.

26 Jan 2022

Cannabidiol inhibits SARS-CoV-2 replication in human cells and mice

In research recently published in the journal of Science Advances, an interdisciplinary team of researchers from the University of Chicago assessed the potential role of cannabidiol (CBD), a natural product extracted from the cannabis plant, to prevent and inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in human cells and mice.

26 Jan 2022

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice.

21 Jan 2022

Cannabis companies flout state regulations to market products in a way that appeals to children

Many recreational cannabis companies market their products in a way that appeals to children and teens, despite state-based regulations prohibiting it, according to a new study in the Journal of Studies on Alcohol and Drugs.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

Cannabidiol may improve innate immune response against SARS-CoV-2

A recent study shows evidence that cannabidiol, an important active ingredient in the Cannabis sativa plant, can augment the antiviral innate immune response and prophylactically prime the innate antiviral response of cells – enabling in turn improved response against viruses such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

16 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

Cannabis News and Research

Latest Cannabis News and Research

Research shows the importance of stopping drug use in early adulthood

Scientific statement highlights the uncertainty about health effects of marijuana

HORIBA Presenting Short Course on Rapid Analysis of Hemp/Cannabis and other Botanicals with Pittcon

Study finds gender-based differences in risk factors associated with anxiety during the pandemic

Cannabis combined with alcohol is more detrimental to driving, finds study

Study explores how cannabis use affects driving performance

Cannabidiol inhibits SARS-CoV-2 replication in human cells and mice

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

Cannabis companies flout state regulations to market products in a way that appeals to children

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Cannabidiol may improve innate immune response against SARS-CoV-2

Cannabinoids may prevent infection with SARS-CoV-2, including variants

Hemp compounds show ability to prevent the entry of SARS-CoV-2 into cells

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

ED visits for pediatric poisonings increased nine times following cannabis legalization

Medical marijuana users brace for shortages as Montana’s recreational market opens

Prescription drug misuse later in life linked to increased odds of substance use disorder

Inhaled CBD shrinks glioblastoma’s size in an animal model

Children and adolescents with persistent high levels of anxiety at greater risk for later psychosis

Cannabinoid medicines have enormous therapeutic potential but reliable studies still lacking

Pittcon Highlights: Cannabis & Psychedelics eBook

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™